Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Mor crawled date : 2022 - 10 - 27 save search
GSK, MorphoSys' Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis
Published: 2022-10-27 (Crawled : 08:00) - biospace.com/
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: -3.82%
H: 6.9%
C: 6.49%
program update
Genomma Lab Internacional Announces Third Dividend Payment - October 27, 2022 Genomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange...
Published: 2022-10-27 (Crawled : 08:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -0.56%
H: 0.84%
C: -0.59%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: -3.82%
H: 6.9%
C: 6.49%
MIRM | $24.42 1.03% 0.94% 420K
|
Health Technology
|
| O: 0.48%
H: 2.41%
C: -7.81%
ARGX | $375.08 1.72% 1.7% 310K
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: -3.71%
payment
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.